MORPHIC THERAPEUTIC

morphic-therapeutic-logo

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic was created in 2015 with co-founders Polaris Partners, T.A. Springer and Schrödinger, Inc., along with ShangPharma Investment Group.

#SimilarOrganizations #People #Financial #Event #Website #More

MORPHIC THERAPEUTIC

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2015-01-01

Address:
Waltham, Massachusetts, United States

Country:
United States

Website Url:
http://www.morphictx.com

Total Employee:
51+

Status:
Active

Contact:
(781)996-0955

Email Addresses:
[email protected]

Total Funding:
134.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

aditxt-therapeutics-logo

Aditxt Therapeutics

Aditxt Therapeutics is a biotechnology company that develops a novel nucleic acid-based technology.

affinia-therapeutics-logo

Affinia Therapeutics

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

antheia-logo

Antheia

A synthetic biology company for next generation plant-inspired medicines

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

eneura-therapeutics-logo

eNeura Therapeutics

ENeura Therapeutics is a medical technology company developing transcranial magnetic stimulation devices for the treatment of migraines.

forge-therapeutics-logo

Forge Therapeutics

Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry.

pinteon-therapeutics-logo

Pinteon Therapeutics

Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

seismic-therapeutic-logo

Seismic Therapeutic

Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.

tango-therapeutics-logo

Tango Therapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

theolytics-logo

Theolytics

Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.


Current Advisors List

ramy-farid_image

Ramy Farid Board of Directors @ Morphic Therapeutic
Board_member

susannah-gray_image

Susannah Gray Board Member @ Morphic Therapeutic
Board_member
2021-04-01

nilesh-kumar_image

Nilesh Kumar Board Of Director @ Morphic Therapeutic
Board_member

amir-nashat_image

Amir Nashat Board Member @ Morphic Therapeutic
Board_member
2017-07-01

timothy-a-springer_image

Timothy A. Springer Founder @ Morphic Therapeutic
Board_member

otello-stampacchia_image

Otello Stampacchia Board Of Director @ Morphic Therapeutic
Board_member

kevin-bitterman_image

Kevin Bitterman Board Member @ Morphic Therapeutic
Board_member

not_available_image

Gustav A. Christensen Board Member @ Morphic Therapeutic
Board_member

Current Employees Featured

not_available_image

Alexey Lugovskoy
Alexey Lugovskoy CDO @ Morphic Therapeutic
CDO
2016-01-01

bruce-rogers_image

Bruce Rogers
Bruce Rogers President @ Morphic Therapeutic
President
2022-05-01

peter-g-linde_image

Peter G. Linde
Peter G. Linde CMO @ Morphic Therapeutic
CMO
2020-03-01

blaise-lippa_image

Blaise Lippa
Blaise Lippa Chief Scientific Officer @ Morphic Therapeutic
Chief Scientific Officer
2022-05-01

marc-schegerin_image

Marc Schegerin
Marc Schegerin COO & CFO @ Morphic Therapeutic
COO & CFO
2020-04-01

praveen-tipirneni_image

Praveen Tipirneni
Praveen Tipirneni CEO @ Morphic Therapeutic
CEO
2015-07-01

joseph-slattery_image

Joseph Slattery
Joseph Slattery Director, Audit Committee Chair and Member of the Compensation Committe @ Morphic Therapeutic
Director, Audit Committee Chair and Member of the Compensation Committe
2019-05-01

timothy-a-springer_image

Timothy A. Springer
Timothy A. Springer Founder @ Morphic Therapeutic
Founder

not_available_image

Robert Farrell Jr.
Robert Farrell Jr. Sr. Vice President Finance & CAO @ Morphic Therapeutic
Sr. Vice President Finance & CAO
2015-01-01

not_available_image

William DeVaul
William DeVaul General Counsel, Corporate Secretary and Chief Compliance Officer @ Morphic Therapeutic
General Counsel, Corporate Secretary and Chief Compliance Officer
2019-02-01

Founder


timothy-a-springer_image

Timothy A. Springer

Stock Details


Company's stock symbol is NASDAQ:MORF

Investors List

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Series B - Morphic Therapeutic

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series B - Morphic Therapeutic

invus_image

Invus

Invus investment in Series B - Morphic Therapeutic

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series B - Morphic Therapeutic

shangpharma_image

ShangPharma

ShangPharma investment in Series B - Morphic Therapeutic

schrodinger_image

Schrödinger

Schrödinger investment in Series B - Morphic Therapeutic

timothy-a--springer_image

Timothy A. Springer

Timothy A. Springer investment in Series B - Morphic Therapeutic

sr-one_image

SR One

SR One investment in Series B - Morphic Therapeutic

omega-funds_image

Omega Funds

Omega Funds investment in Series B - Morphic Therapeutic

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series B - Morphic Therapeutic

Official Site Inspections

http://www.morphictx.com Semrush global rank: 3.52 M Semrush visits lastest month: 4.2 K

  • Host name: 172.67.168.134
  • IP address: 172.67.168.134
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Morphic Therapeutic"

Our Subsidiaries | Eli Lilly and Company

We've been pioneering discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Our wholly-owned subsidiaries are vital to our pursuit of breakthrough science and speeding the discovery …See details»

Morphic Therapeutic - Crunchbase Company Profile

Contact Email [email protected] Phone Number (781)996-0955 Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases, including autoimmune, cardiovascular, and …See details»

Morphic Therapeutic Headquarters & Corporate Office

Morphic Therapeutic is an American biotechnology company that focuses on developing ...See details»

Morphic Therapeutic - LinkedIn

Morphic Therapeutic | 7,313 followers on LinkedIn. Wholly owned subsidiary of Eli Lilly and Company | Oral integrin therapies for patients with immunological, fibrotic, neoplastic and …See details»

Morphic Therapeutic - Company Profile & Staff Directory

Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who …See details»

Morphic Therapeutic Information - RocketReach

Morphictx.com; 1 215280XXXX; Bryan Goodwin Senior Vice President, Head of Biology and Translational Sciences at Morphic Therapeutic Boston, MA, US View. 2 morphictx.com; …See details»

Morphic Therapeutic, Inc. - Drug pipelines, Patents, Clinical trials ...

6 days ago www.morphictx.com. Public Company | Subsidiary Company | 2015 | Massachusetts, United States | 100-250 | NASDAQ: MORF | www.morphictx.com. Last update 27 Dec 2024. …See details»

Morphic Therapeutic - Company Profile - Tracxn

Dec 9, 2024 Morphic Therapeutic - Developer of small molecule integrin inhibitors for immunological, fibrotic, neoplastic and vascular diseases. Acquired by Lilly. Raised a total …See details»

Morphic Therapeutic - Overview, News & Similar companies

Jul 29, 2024 Morphic Therapeutic contact info: Phone number: (781) 996-0955 Website: www.morphictx.com What does Morphic Therapeutic do? Drawing on discoveries made in the …See details»

Morphic Therapeutic - Craft

Aug 16, 2024 Morphic Therapeutic has 4 employees at their 1 location and $521 k in annual revenue in FY 2023. See insights on Morphic Therapeutic including office locations, …See details»

Morphic Therapeutic Overview | SignalHire Company Profile

Annual Revenue 38.8M. Revenue dynamics are not stable. After decline in Q4 2020 and Q1 2021, there is a growth in revenue in Q2 2021. As a result, the company's quarterly revenue …See details»

Working At Morphic Therapeutic: Company Overview and Culture

Mar 14, 2024 morphictx.com. Organization Type. Public. CEO. Praveen P. Tipirneni. Social Media. Morphic Therapeutic is a biotechnology company developing a new generation of oral …See details»

Morphic Therapeutic (USA) Funding: $510.5M - medicalstartups.org

Dec 19, 2024 Website: https://morphictx.com Morphic Therapeutic is developing oral, small-molecule formulations aimed at the family of common cell-surface receptors linked to …See details»

Morphic Therapeutic, Inc. (Morphic Therapeutic, Inc.) - 药物管线_ …

A review.Over the last forty years, recombinant antibodies have been transformed from an unproven exptl. approach to a therapeutic modality with multiple success stories in the …See details»

Morphic Therapeutic - Work in biotech

Morphic Therapeutic is developing a new generation of oral integrin therapies to treat autoimmune, cardiovascular and metabolic diseases. Integrins are receptors found at the cell …See details»

Morphic Therapeutic: Revolutionizing Oral Integrin Treatments

Oct 1, 2024 Explore Morphic Therapeutic's innovative oral integrin therapies for chronic diseases, their drug pipeline, partnerships, and potential market impact.See details»

Lilly to Acquire Morphic to Improve Outcomes for Patients with ...

Morphic's lead program is a selective oral small molecule inhibitor of α4β7 integrin for the treatment of inflammatory bowel disease (IBD) that has the potential to improve outcomes and …See details»

Morphic Holding, Inc. - Cruelty Free Investing

Company Website: https://morphictx.com Contact: [email protected] ©2024 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization …See details»

Working at Morphic Therapeutic - Glassdoor

Morphic Therapeutic is leading the development of a new generation of oral integrin drugs. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic is …See details»

Morphic Consumer Health Privacy Notice – Morphic Therapeutic

There may be certain exceptions that apply to your request. To exercise your rights, you or your authorized representative may submit a request to [email protected] or 781-996-0955. …See details»

linkstock.net © 2022. All rights reserved